Fig. 6From: Novel organoid construction strategy for non-involuting congenital hemangioma for drug validation Clinical medical validation. (A), propranolol (B), sirolimus (C) propranolol. NICH organoids were treated with propranolol, sirolimus or trametinib for 24 and 48 h at 10 µg/ml, 40 µg/ml and 160 µg/ml. Scale bar = 100 μmBack to article page